Stoke Therapeutics, Inc. (STOK) Nonoperating Income (Expense) USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Stoke Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2024.
  • Stoke Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $2 M, a 6.85% decline year-over-year.
  • Stoke Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $9.93 M, a 87.7% increase year-over-year.
  • Stoke Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $10.1 M, a 206% increase from 2022.
  • Stoke Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $3.29 M, a 1165% increase from 2021.
  • Stoke Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $260 K, a 67.5% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $9.93 M $2 M -$147 K -6.85% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $10.1 M $2.63 M +$1.11 M +73% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 $8.97 M $2.69 M +$1.66 M +160% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $7.31 M $2.61 M +$2.02 M +345% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $5.29 M $2.15 M +$2 M +1369% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $3.29 M $1.52 M +$1.44 M +1849% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 $1.85 M $1.04 M +$951 K +1106% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $896 K $586 K +$524 K +845% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $372 K $146 K +$112 K +329% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $260 K $78 K +$53 K +212% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 $207 K $86 K +$59 K +219% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $148 K $62 K +$9 K +17% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $139 K $34 K -$662 K -95.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $801 K $25 K -$884 K -97.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $1.69 M $27 K -$1.21 M -97.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $2.9 M $53 K -$573 K -91.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $3.47 M $696 K +$116 K +20% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $3.35 M $909 K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 $1.24 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $626 K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $580 K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.